comparemela.com

Latest Breaking News On - Earnings history for rocket pharmaceuticals - Page 1 : comparemela.com

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Kinnari-patel
Gaurav-shah
Rocket-pharmaceuticals-trading-down
Nasdaq
Earnings-history-for-rocket-pharmaceuticals
Needham-company
Securities-exchange-commission
Rocket-pharmaceuticals
Goldman-sachs-group
Jpmorgan-chase-co
News-ratings-for-rocket-pharmaceuticals-daily
Rocket-pharmaceuticals-inc

Rocket Pharmaceuticals (NASDAQ:RCKT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Rocket Pharmaceuticals (NASDAQ:RCKT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kinnari-patel
Davidp-southwell
Rocket-pharmaceuticals-inc
News-ratings-for-rocket-pharmaceuticals-daily
Jpmorgan-chase-co
Goldman-sachs-group
Securities-exchange-commission
Rocket-pharmaceuticals
Earnings-history-for-rocket-pharmaceuticals
Cantor-fitzgerald
Rocket-pharmaceuticals-stock-performance
Rocket-pharmaceuticals-company-profile

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Earnings Results

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) posted its quarterly earnings data on Monday. The biotechnology company reported ($0.75) EPS for the quarter, beating analysts’ consensus estimates of ($0.81) by $0.06, Briefing.com reports. During the same quarter in the previous year, the business earned ($0.87) EPS. Rocket Pharmaceuticals Trading Down 5.0 % Shares of Rocket […]

Stifel-nicolaus
Gaurav-shah
Gotham-makker
Steward-partners-investment-advisory
Institutional-trading-of-rocket-pharmaceuticals
Rocket-pharmaceuticals
Insider-transactions-at-rocket-pharmaceuticals
Cantor-fitzgerald
Rocket-pharmaceuticals-company-profile
News-ratings-for-rocket-pharmaceuticals-daily
Advisor-group-holdings-inc
Rocket-pharmaceuticals-trading-down

Rocket Pharmaceuticals (NASDAQ:RCKT) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.01), Briefing.com reports. During the same quarter in the prior year, the firm earned ($0.83) EPS. Rocket Pharmaceuticals Trading Down 1.5 % […]

Stifel-nicolaus
Nasdaq
Rocket-pharmaceuticals
Rocket-pharmaceuticals-company-profile
Northern-trust-corp
Geode-capital-management
Earnings-history-for-rocket-pharmaceuticals
Rocket-pharmaceuticals-trading-down
Canaccord-genuity-group
News-ratings-for-rocket-pharmaceuticals-daily
Institutional-investors-weigh-in-on-rocket-pharmaceuticals
Manufacturers-life-insurance-company

Rocket Pharmaceuticals (NASDAQ:RCKT) Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) posted its quarterly earnings data on Thursday. The biotechnology company reported ($0.73) earnings per share for the quarter, beating the consensus estimate of ($0.84) by $0.11, Briefing.com reports. During the same period last year, the company earned ($0.67) earnings per share. Rocket Pharmaceuticals Price Performance Shares of RCKT stock […]

Gaurav-shah
Jonathan-david-schwartz
Rocket-pharmaceuticals-inc
Morgan-stanley
Earnings-history-for-rocket-pharmaceuticals
Dynamic-technology-lab-private-ltd
Rocket-pharmaceuticals
Metlife-investment-management
Parkman-healthcare-partners
Needham-company
Rocket-pharmaceuticals-price-performance
Hightower-advisors

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.